These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Development of Ciprofloxacin-Loaded Bilosomes In-Situ Gel for Ocular Delivery: Optimization, In-Vitro Characterization, Ex-Vivo Permeation, and Antimicrobial Study. Alsaidan OA; Zafar A; Yasir M; Alzarea SI; Alqinyah M; Khalid M Gels; 2022 Oct; 8(11):. PubMed ID: 36354595 [TBL] [Abstract][Full Text] [Related]
4. A stepwise optimization strategy to formulate Elmotasem H; Awad GEA Asian J Pharm Sci; 2020 Sep; 15(5):617-636. PubMed ID: 33193864 [TBL] [Abstract][Full Text] [Related]
5. Chlorpheniramine maleate containing chitosan-based nanoparticle-loaded thermosensitive in situ gel for management in allergic rhinitis. Kumar M; Upadhayay P; Shankar R; Joshi M; Bhatt S; Malik A Drug Deliv Transl Res; 2019 Dec; 9(6):1017-1026. PubMed ID: 31049842 [TBL] [Abstract][Full Text] [Related]
6. Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: In-vitro characterization, ocular tolerance and antibacterial activity. Ameeduzzafar ; Imam SS; Abbas Bukhari SN; Ahmad J; Ali A Int J Biol Macromol; 2018 Mar; 108():650-659. PubMed ID: 29199125 [TBL] [Abstract][Full Text] [Related]
7. Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration. Silva MM; Calado R; Marto J; Bettencourt A; Almeida AJ; Gonçalves LMD Mar Drugs; 2017 Dec; 15(12):. PubMed ID: 29194378 [TBL] [Abstract][Full Text] [Related]
8. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Gupta H; Jain S; Mathur R; Mishra P; Mishra AK; Velpandian T Drug Deliv; 2007 Nov; 14(8):507-15. PubMed ID: 18027180 [TBL] [Abstract][Full Text] [Related]
9. Improvement in Ocular Bioavailability and Prolonged Delivery of Tobramycin Sulfate Following Topical Ophthalmic Administration of Drug-Loaded Mucoadhesive Microparticles Incorporated in Thermosensitive In Situ Gel. Khan S; Warade S; Singhavi DJ J Ocul Pharmacol Ther; 2018 Apr; 34(3):287-297. PubMed ID: 29211593 [TBL] [Abstract][Full Text] [Related]
10. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. Motwani SK; Chopra S; Talegaonkar S; Kohli K; Ahmad FJ; Khar RK Eur J Pharm Biopharm; 2008 Mar; 68(3):513-25. PubMed ID: 17983737 [TBL] [Abstract][Full Text] [Related]
11. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study. Singh J; Chhabra G; Pathak K Drug Dev Ind Pharm; 2014 Sep; 40(9):1223-32. PubMed ID: 23837522 [TBL] [Abstract][Full Text] [Related]
12. Design and evaluation of Kalaria VJ; Saisivam S; Alshishani A; Aljariri Alhesan JS; Chakraborty S; Rahamathulla M Drug Deliv; 2023 Dec; 30(1):2185180. PubMed ID: 36876464 [TBL] [Abstract][Full Text] [Related]
13. Development of oral sustained release rifampicin loaded chitosan nanoparticles by design of experiment. Patel BK; Parikh RH; Aboti PS J Drug Deliv; 2013; 2013():370938. PubMed ID: 24024034 [TBL] [Abstract][Full Text] [Related]
14. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies. Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418 [TBL] [Abstract][Full Text] [Related]
15. Vancomycin-loaded niosomes integrated within pH-sensitive in-situ forming gel for treatment of ocular infections while minimizing drug irritation. Allam A; El-Mokhtar MA; Elsabahy M J Pharm Pharmacol; 2019 Aug; 71(8):1209-1221. PubMed ID: 31124593 [TBL] [Abstract][Full Text] [Related]
16. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept. Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613 [TBL] [Abstract][Full Text] [Related]
17. Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes. Vigani B; Rossi S; Sandri G; Bonferoni MC; Caramella CM; Ferrari F Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32927595 [TBL] [Abstract][Full Text] [Related]
18. Formulation and optimization of mucoadhesive nanodrug delivery system of acyclovir. Bhosale U; Kusum DV; Jain N J Young Pharm; 2011 Oct; 3(4):275-83. PubMed ID: 22224033 [TBL] [Abstract][Full Text] [Related]
19. Protein Nanoparticles Laden Pillai AR; Prajapati B; Dharamsi A Curr Drug Deliv; 2024; 21(1):38-51. PubMed ID: 36694323 [TBL] [Abstract][Full Text] [Related]
20. Development and Characterization of Oral Raft Forming In Situ Gelling System of Neratinib Anticancer Drug Using 3 Hani U; Rahamathulla M; Osmani RAM; Begum MY; Wahab S; Ghazwani M; Fatease AA; Alamri AH; Gowda DV; Alqahtani A Polymers (Basel); 2022 Jun; 14(13):. PubMed ID: 35808569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]